Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis [version 1; referees: 2 approved]
Drug-induced Immune Haemolytic Anaemia (DIIHA) is a rare but serious complication of cephalosporin use. Ceftazidime is recognized to be a rare cause of DIIHA. We report and discuss a case of DIIHA in a person with cystic fibrosis who developed severe haemolytic anaemia following use of ceftazidime i...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-04-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/7-475/v1 |